Effects of Forskolin on Endogenous Dopamine and Acetylcholine Release in Rat Neostriatal Slices

  • Published : 1996.12.01

Abstract

The involvement of the cyclic AMP (cAMP) effector system in the release of endogenous dopamine and acetylcholine from the rat neostriatum was assessed. Forskolin, an activator of adenylate cyclase, was used to enhance cAMP production, and the consequence of this enhancement on the spontaneous and potassium stimulated release of dopamine and acetylcholine was evaluated. Neostriatal slices were prepared from Fischer 344 rats and after a preincubation period the release of each endogenous neurotransmitter was measured from the same slice preparation. To measure acetylcholine release the slice acetylcholinesterase (AChE) activity was inhibited with physostigmine, but the release from slices with intact AChE activity was also determined (choline, instead of acetylcholine was detected in the medium). Under both conditions forskolin induced a significant dose-dependent increase in the potassium-evoked release of dopamine. In the same tissue preparations the release of neither acetylcholine (AChE inhibited) nor choline (AChE intact) was affected by forskolin. The results indicate that the CAMP second messenger system might be involved in neuronal mechanisms that enhance neostriatal dopamine release, but stimulation of this second messenger by forskolin does not further enhance neostriatal acetylcholine release.

Keywords

References

  1. J. Neurosci. v.5 Nerve growth factor treatment enhances nicotine-stimulated dopamine release and increases in cyclic adenosine $3^1:5^1$-monophosphate levels in PC 12 cell cultures Baizer,L.;Weiner,N.
  2. Naunyn Schmiedeberg's Arch. Pharmacol. v.328 Different approaches to study acetylcholine release: endogenous ACh verses tritium efflux Beani,L.;Bianchi,C.;Siniscalchi,A.;Sivilotti,L.;Tanganelli,S.;Veratti,E.
  3. J. Pharmacol. Exp. Ther. v.248 $K^ +$-channel and adenylate cyclase involvement in regulation of $Ca^ {++}$-evoked release of $[^ 3H]$dopamine from synaptosomes Bowyer,J.F.;Weiner,N.
  4. Br. J. Pharmacol. v.93 Longterm regulation of synaptic acetylcholine release and nicotinic transmission Briggs,C.A.;McAfee,D.A.;McCaman,R.E.
  5. J. Neurochem. v.41 Frequency-dependent release of acetylcholine and dopamine from rabbit striatum: its modulation by dopaminergic receptors Cubeddu,L.X.;Hoffman,I.S.
  6. Can. J. Physiol. Pharmacol. v.66 Pharmacological elevation of cAMP and transmitter release at the mouse neuromuscular junction Dryden,W.F.;Singh,Y.N.;Gordon,T.;Lazarenko,G.
  7. J. Neurochem. v.24 Plasma choline, its turnover and exchange with brain choline Freeman,J.J.;Choi,R.L.;Jenden,D.J.
  8. Brain Res. v.348 Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: Effects of depolizing stimuli, amphetamine and synthesis inhibition Herdon,H.;Strupish,J.;Nahorski,S.R.
  9. Anal. Biochem. v.55 Simultaneous measurement of endogenous and deuterium labeled tracer variants of choline and acetylcholine in subpicomole quantities by gas chromatography mass spectrometry Jenden,D.J.;Roch,M.;Booth,R.
  10. Neurochemical Res. v.16 Effects of various experimental manipulation on neostriatal acetylcholine and dopamine release Lee,H.J.;Alcorn,L.M.;Weiler,M.H.
  11. Brain Res. v.248 Muscarinic receptors on dopamine terminals in the cat caudate nucleus: Neuromodulation of $[^ 3H]$dopamine release in vitro by endogenous acetylcholine Lehman,J.;Langer.S.Z.
  12. Neurosci. v.10 The striatal cholinergic interaction: synaptic target of dopaminergic terminals Lehman,J.;Langer,S.Z.
  13. J. Biol. Chem. v.193 Protein measurement with the Folin reagent Lowry,O.H.;Rosebrough,N.J.;Farr,A.L.;Randall,R.J.
  14. Naunyn Schmeideberg's Arch. Pharmacol. v.325 Forskolin and the release of noradrenaline in cerebrocortical slices Markstein,R.;Digges,K.;Marshall,N.R.;Starke,K.
  15. Mol. Cell. Biochem. v.53/54 Tyrosine hydroxylase regulation in the central nervous system Masserano,J.M.;Weiner,N.
  16. Practical Neurochemistry Preparing neural tissues for metabolic study in vitro McIlwain,H.;Rodnight,R.;McIlwain.H(eds.)
  17. J. Pharmacol. Exp. Ther. v.197 Dopamine synthesis in rat brain striatal synaptosomes.Ⅱ. Dibutyryl cyclic adenosine $3^ 1:5^ 1$-monophosphoric acid and 6-methyltetrahydropteridine-induced synthesis increase without an increase in endogenous dopamine release Patrick,R.L.;Barchas,J.D.
  18. Biochemical Pharmacol. v.33 Stimulation of acetylcholine release from Guinea-pig ileal synaptosomes by cyclic nucleotides and forskolin Reese,J.H.;Cooper,J.R.
  19. Trends Pharmacol. Sci. v.4 Forskolin, cyclic AMP and celluar physiology Seamon,K.B.;Daly,J.W.
  20. Proc. Natl. Acad. Sci. USA v.78 Forskolin: Unique diterpene activator of adenylate cyclase in membranes and in intact cells Seamon,K.B.;Padgett,W.;Daly,J.W.
  21. Brain Res. v.250 Independent in vitro regulation by D2-dopamine receptor of dopamine-stimulated efflux of cAMP and $K^ +$-stimulated release of acetylcholine from rat neostriatum Stoof,J.C.;Kebabian,K.W.
  22. Arch. Int. Pharmacodyn.Ther. v.279 Facilitation of acetylcholine-evoked CA release by cAMP on isolated perfused dog adrenal glands Tsujimoto,A.;Morita,K.;Kitayama,S.;Dohi,T.
  23. J. Pharm. Exp. Ther. v.250 Muscarinic modulation of endogenous acetylcholine release in rat neostriatal slices Weiler,M.H.
  24. Brain Res. v.463 Forskolin attenuates the evoked release of $[^ 3H]$GABA from s striatal neurons in primary culture Weiss,S.
  25. J. Pharmacol. Exp. Ther. v.243 Stimulation of acetylcholine release from myenteric neurons of Guinea pig small intestine by forskolin Yau,W.M.;Dorsett,J.A.;Youther,M.L.